Search

everythinglearnresearchcommunity

for

Search:↓

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

The document concludes that modern photo stories help represent and challenge how breast cancer affects women's identities and societal norms.

Finasteride may not affect gynecomastia recurrence after mastectomy.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Ayurveda, using herbs like ginger, garlic, and turmeric, can reduce chemo-radiotherapy side effects in cancer patients.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

A group has developed therapies that show promise for treating cancer and various other conditions.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.